Mesalazine-Induced Myopericarditis in a Patient with a Recent Diagnosis of Crohn’s Disease: Apropos of a Case

Mesalazine- (5-aminosalicylic acid-) containing products are a well-known treatment for inflammatory bowel disease, often as first line. Myocarditis is recognized as a very rare possible side effect of this drug treatment. We present a case of mesalazine-induced myopericarditis that was successfully...

Full description

Saved in:
Bibliographic Details
Main Authors: Michele Sorleto, Stefanie Dürrwald, Marcus Wiemer
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Case Reports in Cardiology
Online Access:http://dx.doi.org/10.1155/2015/728310
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832545640584839168
author Michele Sorleto
Stefanie Dürrwald
Marcus Wiemer
author_facet Michele Sorleto
Stefanie Dürrwald
Marcus Wiemer
author_sort Michele Sorleto
collection DOAJ
description Mesalazine- (5-aminosalicylic acid-) containing products are a well-known treatment for inflammatory bowel disease, often as first line. Myocarditis is recognized as a very rare possible side effect of this drug treatment. We present a case of mesalazine-induced myopericarditis that was successfully improved by immediate cessation of the medication.
format Article
id doaj-art-42dbe2fafde646649c0930bdb2384adc
institution Kabale University
issn 2090-6404
2090-6412
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Case Reports in Cardiology
spelling doaj-art-42dbe2fafde646649c0930bdb2384adc2025-02-03T07:25:08ZengWileyCase Reports in Cardiology2090-64042090-64122015-01-01201510.1155/2015/728310728310Mesalazine-Induced Myopericarditis in a Patient with a Recent Diagnosis of Crohn’s Disease: Apropos of a CaseMichele Sorleto0Stefanie Dürrwald1Marcus Wiemer2Department of Cardiology, Johannes-Wesling-Klinikum Minden, Hans-Nolte-Strasse 1, 32429 Minden, GermanyDepartment of Cardiology, Johannes-Wesling-Klinikum Minden, Hans-Nolte-Strasse 1, 32429 Minden, GermanyDepartment of Cardiology, Johannes-Wesling-Klinikum Minden, Hans-Nolte-Strasse 1, 32429 Minden, GermanyMesalazine- (5-aminosalicylic acid-) containing products are a well-known treatment for inflammatory bowel disease, often as first line. Myocarditis is recognized as a very rare possible side effect of this drug treatment. We present a case of mesalazine-induced myopericarditis that was successfully improved by immediate cessation of the medication.http://dx.doi.org/10.1155/2015/728310
spellingShingle Michele Sorleto
Stefanie Dürrwald
Marcus Wiemer
Mesalazine-Induced Myopericarditis in a Patient with a Recent Diagnosis of Crohn’s Disease: Apropos of a Case
Case Reports in Cardiology
title Mesalazine-Induced Myopericarditis in a Patient with a Recent Diagnosis of Crohn’s Disease: Apropos of a Case
title_full Mesalazine-Induced Myopericarditis in a Patient with a Recent Diagnosis of Crohn’s Disease: Apropos of a Case
title_fullStr Mesalazine-Induced Myopericarditis in a Patient with a Recent Diagnosis of Crohn’s Disease: Apropos of a Case
title_full_unstemmed Mesalazine-Induced Myopericarditis in a Patient with a Recent Diagnosis of Crohn’s Disease: Apropos of a Case
title_short Mesalazine-Induced Myopericarditis in a Patient with a Recent Diagnosis of Crohn’s Disease: Apropos of a Case
title_sort mesalazine induced myopericarditis in a patient with a recent diagnosis of crohn s disease apropos of a case
url http://dx.doi.org/10.1155/2015/728310
work_keys_str_mv AT michelesorleto mesalazineinducedmyopericarditisinapatientwitharecentdiagnosisofcrohnsdiseaseaproposofacase
AT stefaniedurrwald mesalazineinducedmyopericarditisinapatientwitharecentdiagnosisofcrohnsdiseaseaproposofacase
AT marcuswiemer mesalazineinducedmyopericarditisinapatientwitharecentdiagnosisofcrohnsdiseaseaproposofacase